ASX - By Stock
|
KP2 |
Re:
Exciting Times For KP2
|
|
vaxjopies
|
398 |
139K |
3 |
30/03/22 |
30/03/22 |
ASX - By Stock
|
398
|
139K
|
3
|
|
ASX - By Stock
|
KP2 |
Re:
Exciting Times For KP2
|
|
vaxjopies
|
398 |
139K |
4 |
30/03/22 |
30/03/22 |
ASX - By Stock
|
398
|
139K
|
4
|
|
ASX - By Stock
|
KP2 |
Re:
Exciting Times For KP2
|
|
vaxjopies
|
398 |
139K |
1 |
25/03/22 |
25/03/22 |
ASX - By Stock
|
398
|
139K
|
1
|
|
ASX - By Stock
|
KP2 |
Re:
Exciting Times For KP2
|
|
vaxjopies
|
398 |
139K |
3 |
25/03/22 |
25/03/22 |
ASX - By Stock
|
398
|
139K
|
3
|
|
Charts
|
EMV |
Re:
Chart
|
|
vaxjopies
|
2.8K |
1.5M |
6 |
23/03/22 |
23/03/22 |
Charts
|
2.8K
|
1.5M
|
6
|
|
Charts
|
EMV |
Re:
Chart
|
|
vaxjopies
|
2.8K |
1.5M |
4 |
23/03/22 |
23/03/22 |
Charts
|
2.8K
|
1.5M
|
4
|
|
ASX - By Stock
|
EMV |
Re:
Great interview / presentation with Scott on ***.
|
|
vaxjopies
|
13 |
5.5K |
14 |
17/03/22 |
17/03/22 |
ASX - By Stock
|
13
|
5.5K
|
14
|
|
ASX - By Stock
|
KP2 |
Re:
US$800/t Potash Spot Price
|
|
vaxjopies
|
37 |
12K |
0 |
11/03/22 |
11/03/22 |
ASX - By Stock
|
37
|
12K
|
0
|
|
ASX - By Stock
|
KP2 |
Re:
US$800/t Potash Spot Price
|
|
vaxjopies
|
37 |
12K |
1 |
11/03/22 |
11/03/22 |
ASX - By Stock
|
37
|
12K
|
1
|
|
ASX - By Stock
|
AZY |
Re:
Knocks the lights out.
|
|
vaxjopies
|
25 |
18K |
14 |
09/03/22 |
09/03/22 |
ASX - By Stock
|
25
|
18K
|
14
|
|
ASX - By Stock
|
KP2 |
Re:
US$800/t Potash Spot Price
|
|
vaxjopies
|
37 |
12K |
1 |
07/03/22 |
07/03/22 |
ASX - By Stock
|
37
|
12K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
vaxjopies
|
4.1K |
1.9M |
1 |
02/03/22 |
02/03/22 |
ASX - By Stock
|
4.1K
|
1.9M
|
1
|
|
ASX - By Stock
|
AZY |
Re:
Ann: Further High-Grade Gold Results at 100% Minyari Deposit
|
|
vaxjopies
|
100 |
42K |
19 |
10/02/22 |
10/02/22 |
ASX - By Stock
|
100
|
42K
|
19
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
vaxjopies
|
4.2K |
3.8M |
8 |
08/02/22 |
08/02/22 |
ASX - By Stock
|
4.2K
|
3.8M
|
8
|
|
ASX - By Stock
|
AGN |
Re:
AGN media and scientific papers
|
|
vaxjopies
|
21 |
8.4K |
4 |
17/01/22 |
17/01/22 |
ASX - By Stock
|
21
|
8.4K
|
4
|
|
Charts
|
EMV |
Re:
Chart
|
|
vaxjopies
|
2.8K |
1.5M |
0 |
13/01/22 |
13/01/22 |
Charts
|
2.8K
|
1.5M
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PARADIGM TREATS FIRST SUBJECTS IN PHASE 3 TRIAL OF ZILOSUL
|
|
vaxjopies
|
42 |
17K |
4 |
13/01/22 |
13/01/22 |
ASX - By Stock
|
42
|
17K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
vaxjopies
|
4.2K |
3.8M |
2 |
11/01/22 |
11/01/22 |
ASX - By Stock
|
4.2K
|
3.8M
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
vaxjopies
|
4.2K |
3.8M |
3 |
11/01/22 |
11/01/22 |
ASX - By Stock
|
4.2K
|
3.8M
|
3
|
|
ASX - By Stock
|
PAR |
Re:
PAR General discussion
|
|
vaxjopies
|
339 |
138K |
1 |
11/01/22 |
11/01/22 |
ASX - By Stock
|
339
|
138K
|
1
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Change of Director's Interest Notice
|
|
vaxjopies
|
9 |
3.4K |
15 |
11/01/22 |
11/01/22 |
ASX - By Stock
|
9
|
3.4K
|
15
|
|
ASX - By Stock
|
AZY |
Re:
Break out happening
|
|
vaxjopies
|
637 |
277K |
2 |
10/01/22 |
10/01/22 |
ASX - By Stock
|
637
|
277K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR REPORTS POSTIVE TOPLINE RESULTS IN HEART FAILURE MODEL
|
|
vaxjopies
|
45 |
16K |
3 |
16/12/21 |
16/12/21 |
ASX - By Stock
|
45
|
16K
|
3
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
vaxjopies
|
2.5K |
1.2M |
7 |
14/12/21 |
14/12/21 |
ASX - By Stock
|
2.5K
|
1.2M
|
7
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Investor Presentation
|
|
vaxjopies
|
6 |
2.7K |
4 |
30/11/21 |
30/11/21 |
ASX - By Stock
|
6
|
2.7K
|
4
|
|
ASX - By Stock
|
AGN |
Re:
Ann: AGM Presentation
|
|
vaxjopies
|
10 |
4.2K |
9 |
19/11/21 |
19/11/21 |
ASX - By Stock
|
10
|
4.2K
|
9
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
vaxjopies
|
4.2K |
3.8M |
8 |
18/11/21 |
18/11/21 |
ASX - By Stock
|
4.2K
|
3.8M
|
8
|
|
ASX - By Stock
|
ECT |
Re:
Ann: Strategic Review & Corporate Update
|
|
vaxjopies
|
388 |
105K |
2 |
10/11/21 |
10/11/21 |
ASX - By Stock
|
388
|
105K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Trading Halt
|
|
vaxjopies
|
150 |
74K |
5 |
01/11/21 |
01/11/21 |
ASX - By Stock
|
150
|
74K
|
5
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
vaxjopies
|
13 |
4.1K |
9 |
28/10/21 |
28/10/21 |
ASX - By Stock
|
13
|
4.1K
|
9
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Quarterly Update and Appendix 4C - quarterly
|
|
vaxjopies
|
7 |
8.9K |
7 |
28/10/21 |
28/10/21 |
ASX - By Stock
|
7
|
8.9K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Phase 2 Synovial Fluid Biomarker Study Update
|
|
vaxjopies
|
76 |
24K |
11 |
26/10/21 |
26/10/21 |
ASX - By Stock
|
76
|
24K
|
11
|
|
ASX - By Stock
|
AZY |
Re:
Ann: Further High-Grade Gold Results at 100% Minyari Deposit
|
|
vaxjopies
|
110 |
41K |
13 |
07/10/21 |
07/10/21 |
ASX - By Stock
|
110
|
41K
|
13
|
|
Charts
|
EMV |
Re:
Chart
|
|
vaxjopies
|
2.8K |
1.5M |
6 |
30/09/21 |
30/09/21 |
Charts
|
2.8K
|
1.5M
|
6
|
|
ASX - By Stock
|
AZY |
Re:
Break out looming
|
|
vaxjopies
|
493 |
188K |
2 |
09/09/21 |
09/09/21 |
ASX - By Stock
|
493
|
188K
|
2
|
|
ASX - By Stock
|
EMV |
Re:
Ann: 1st Gen Device Successfully Manufactured & Ready for Testing
|
|
vaxjopies
|
81 |
24K |
3 |
12/08/21 |
12/08/21 |
ASX - By Stock
|
81
|
24K
|
3
|
|
ASX - By Stock
|
ADD |
Re:
Ann: Appendix 3Y - Grant Pierce
|
|
vaxjopies
|
3 |
1.1K |
6 |
12/08/21 |
12/08/21 |
ASX - By Stock
|
3
|
1.1K
|
6
|
|
ASX - By Stock
|
ADD |
Re:
Ann: Maiden Drillhole Intercepts Ni and Cu bearing Sulphide Veins
|
|
vaxjopies
|
91 |
30K |
0 |
11/08/21 |
11/08/21 |
ASX - By Stock
|
91
|
30K
|
0
|
|
ASX - By Stock
|
EMV |
Re:
Ann: 1st Gen Device Successfully Manufactured & Ready for Testing
|
|
vaxjopies
|
81 |
24K |
19 |
10/08/21 |
10/08/21 |
ASX - By Stock
|
81
|
24K
|
19
|
|
ASX - By Stock
|
PAR |
Re:
Conference Call 3/8/21
|
|
vaxjopies
|
65 |
22K |
5 |
04/08/21 |
04/08/21 |
ASX - By Stock
|
65
|
22K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PARADIGM REPORTS IND APPLICATION UPDATE
|
|
vaxjopies
|
150 |
60K |
2 |
03/08/21 |
03/08/21 |
ASX - By Stock
|
150
|
60K
|
2
|
|
ASX - By Stock
|
AZY |
Re:
Break out looming
|
|
vaxjopies
|
493 |
188K |
4 |
30/07/21 |
30/07/21 |
ASX - By Stock
|
493
|
188K
|
4
|
|
ASX - By Stock
|
AZY |
Re:
Break out looming
|
|
vaxjopies
|
493 |
188K |
4 |
27/07/21 |
27/07/21 |
ASX - By Stock
|
493
|
188K
|
4
|
|
ASX - By Stock
|
AZY |
Re:
Ann: Discovery of Significant Zones of High-Grade Gold at Minyari
|
|
vaxjopies
|
172 |
63K |
5 |
13/07/21 |
13/07/21 |
ASX - By Stock
|
172
|
63K
|
5
|
|
ASX - By Stock
|
THB |
Re:
VAL: Due diligence
|
|
vaxjopies
|
57 |
27K |
2 |
30/06/21 |
30/06/21 |
ASX - By Stock
|
57
|
27K
|
2
|
|
ASX - By Stock
|
ADD |
Re:
ADD chart
|
|
vaxjopies
|
403 |
107K |
3 |
30/06/21 |
30/06/21 |
ASX - By Stock
|
403
|
107K
|
3
|
|
ASX - By Stock
|
CBL |
Re:
Ann: Appendix 4C - Quarterly
|
|
vaxjopies
|
40 |
17K |
1 |
23/06/21 |
23/06/21 |
ASX - By Stock
|
40
|
17K
|
1
|
|
ASX - By Stock
|
CBL |
Re:
Ann: Appendix 4C - Quarterly
|
|
vaxjopies
|
40 |
17K |
3 |
16/06/21 |
16/06/21 |
ASX - By Stock
|
40
|
17K
|
3
|
|
ASX - By Stock
|
CBL |
Re:
Ann: Appendix 4C - Quarterly
|
|
vaxjopies
|
40 |
17K |
3 |
16/06/21 |
16/06/21 |
ASX - By Stock
|
40
|
17K
|
3
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Successful MRFF Bid
|
|
vaxjopies
|
158 |
50K |
0 |
31/03/21 |
31/03/21 |
ASX - By Stock
|
158
|
50K
|
0
|
|